• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性前淋巴细胞起源于慢性淋巴细胞白血病中的造血干细胞/祖细胞。

Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia.

作者信息

Kikushige Yoshikane, Miyamoto Toshihiro

机构信息

Department of Medicine and Biosystemic Sciences, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.

Japan Society for the Promotion of Science, Tokyo, Japan.

出版信息

Int J Hematol. 2015 Nov;102(5):528-35. doi: 10.1007/s12185-015-1740-1. Epub 2015 Feb 3.

DOI:10.1007/s12185-015-1740-1
PMID:25644149
Abstract

Human malignancies progress through a multistep process that includes the development of critical somatic mutations over the clinical course. Recent novel findings have indicated that hematopoietic stem cells (HSCs), which have the potential to self-renew and differentiate into multilineage hematopoietic cells, are an important cellular target for the accumulation of critical somatic mutations in hematological malignancies and play a central role in myeloid malignancy development. In contrast to myeloid malignancies, mature lymphoid malignancies, such as chronic lymphocytic leukemia (CLL), are thought to originate directly from differentiated mature lymphocytes; however, recent compelling data have shown that primitive HSCs and hematopoietic progenitor cells contribute to the pathogenesis of mature lymphoid malignancies. Several representative mutations of hematological malignancies have been identified within the HSCs of CLL and lymphoma patients, indicating that the self-renewing long-lived fraction of HSCs can serve as a reservoir for the development of oncogenic events. Novel mice models have been established as human mature lymphoma models, in which specific oncogenic events target the HSCs and immature progenitor cells. These data collectively suggest that HSCs can be the cellular target involved in the accumulation of oncogenic events in the pathogenesis of mature lymphoid and myeloid malignancies.

摘要

人类恶性肿瘤通过一个多步骤过程进展,该过程包括在临床病程中关键体细胞突变的发生。最近的新发现表明,具有自我更新和分化为多谱系造血细胞潜能的造血干细胞(HSC),是血液系统恶性肿瘤中关键体细胞突变积累的重要细胞靶点,并且在髓系恶性肿瘤发展中起核心作用。与髓系恶性肿瘤不同,成熟淋巴细胞恶性肿瘤,如慢性淋巴细胞白血病(CLL),被认为直接起源于分化成熟的淋巴细胞;然而,最近令人信服的数据表明,原始造血干细胞和造血祖细胞参与了成熟淋巴细胞恶性肿瘤的发病机制。在CLL和淋巴瘤患者的造血干细胞中已鉴定出几种血液系统恶性肿瘤的代表性突变,这表明造血干细胞中具有自我更新能力的长寿亚群可作为致癌事件发生发展的储存库。已建立了新型小鼠模型作为人类成熟淋巴瘤模型,其中特定致癌事件靶向造血干细胞和未成熟祖细胞。这些数据共同表明,造血干细胞可能是成熟淋巴细胞和髓系恶性肿瘤发病机制中致癌事件积累所涉及的细胞靶点。

相似文献

1
Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia.恶性前淋巴细胞起源于慢性淋巴细胞白血病中的造血干细胞/祖细胞。
Int J Hematol. 2015 Nov;102(5):528-35. doi: 10.1007/s12185-015-1740-1. Epub 2015 Feb 3.
2
Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis.造血干细胞衰老与慢性淋巴细胞白血病发病机制。
Int J Hematol. 2014 Oct;100(4):335-40. doi: 10.1007/s12185-014-1651-6. Epub 2014 Aug 7.
3
Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.自我更新的造血干细胞是人类慢性淋巴细胞白血病发病机制中的主要靶点。
Cancer Cell. 2011 Aug 16;20(2):246-59. doi: 10.1016/j.ccr.2011.06.029.
4
Hematopoietic stem cells: cancer involvement and myeloid leukemia.造血干细胞:癌症累及与髓系白血病
Eur Rev Med Pharmacol Sci. 2015 May;19(10):1829-36.
5
Hematological malignancies: disease pathophysiology of leukemic stem cells.血液系统恶性肿瘤:白血病干细胞的疾病病理生理学
J Stem Cells. 2013;8(3-4):151-87.
6
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity.慢性淋巴细胞白血病中的白血病起始 HSCs 揭示了克隆性白血病发生和药物敏感性的差异。
Cell Rep. 2022 Jul 19;40(3):111115. doi: 10.1016/j.celrep.2022.111115.
7
Wnt Signaling in Hematological Malignancies.Wnt 信号通路在血液系统恶性肿瘤中的作用。
Prog Mol Biol Transl Sci. 2018 Jan;153:321-341. doi: 10.1016/bs.pmbts.2017.11.002. Epub 2017 Dec 29.
8
Tracing the roots of cancer evolution.追溯癌症演变的根源。
Cancer Discov. 2014 Sep;4(9):995-7. doi: 10.1158/2159-8290.CD-14-0743.
9
Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.Dnmt3a 缺失使小鼠造血干细胞易于恶性转化。
Blood. 2015 Jan 22;125(4):629-38. doi: 10.1182/blood-2014-08-594648.
10
Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.Stat5缺陷型造血作用对Myc诱导的B细胞白血病发生是允许的。
Oncotarget. 2015 Oct 6;6(30):28961-72. doi: 10.18632/oncotarget.5009.

引用本文的文献

1
Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia.Tet2是T细胞急性淋巴细胞白血病白血病前期的一种肿瘤抑制因子。
Blood Adv. 2024 Jun 11;8(11):2646-2649. doi: 10.1182/bloodadvances.2023011970.
2
Synchronous diagnosis and treatment of acute myeloid leukemia and chronic lymphocytic leukemia: Two case reports.急性髓系白血病与慢性淋巴细胞白血病的同步诊断与治疗:两例报告
World J Clin Cases. 2021 Oct 26;9(30):9144-9150. doi: 10.12998/wjcc.v9.i30.9144.
3
Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies.

本文引用的文献

1
The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell.II类和I类突变的有序获得指导人类t(8;21)急性髓性白血病干细胞的形成。
Exp Hematol. 2014 Nov;42(11):955-65.e1-5. doi: 10.1016/j.exphem.2014.07.267. Epub 2014 Aug 4.
2
Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis.造血干细胞衰老与慢性淋巴细胞白血病发病机制。
Int J Hematol. 2014 Oct;100(4):335-40. doi: 10.1007/s12185-014-1651-6. Epub 2014 Aug 7.
3
Acquired initiating mutations in early hematopoietic cells of CLL patients.
慢性淋巴细胞白血病的发病机制与新型治疗策略的开发。
J Clin Exp Hematop. 2020 Dec 15;60(4):146-158. doi: 10.3960/jslrt.20036. Epub 2020 Nov 4.
4
Pathophysiology of chronic lymphocytic leukemia and human B1 cell development.慢性淋巴细胞白血病的病理生理学与人类 B1 细胞的发育。
Int J Hematol. 2020 May;111(5):634-641. doi: 10.1007/s12185-019-02788-7. Epub 2019 Dec 3.
慢性淋巴细胞白血病患者早期造血细胞中获得的起始突变。
Cancer Discov. 2014 Sep;4(9):1088-101. doi: 10.1158/2159-8290.CD-14-0104. Epub 2014 Jun 11.
4
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma.Bcl6的瞬时表达足以发挥致癌功能并诱导成熟B细胞淋巴瘤。
Nat Commun. 2014 Jun 2;5:3904. doi: 10.1038/ncomms4904.
5
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia.毛细胞白血病中 BRAFV600E 突变的造血干细胞起源。
Sci Transl Med. 2014 May 28;6(238):238ra71. doi: 10.1126/scitranslmed.3008004.
6
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.急性白血病中白血病前造血干细胞的鉴定。
Nature. 2014 Feb 20;506(7488):328-33. doi: 10.1038/nature13038. Epub 2014 Feb 12.
7
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.血管免疫母细胞性 T 细胞淋巴瘤中的体显性 RHOA 突变。
Nat Genet. 2014 Feb;46(2):171-5. doi: 10.1038/ng.2872. Epub 2014 Jan 12.
8
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.外周 T 细胞淋巴瘤中表观遗传调节因子、RHOA 和 FYN 激酶的反复突变。
Nat Genet. 2014 Feb;46(2):166-70. doi: 10.1038/ng.2873. Epub 2014 Jan 12.
9
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.综合基因组分析鉴定出了推动滤泡性淋巴瘤发生和进展的反复突变和演化模式。
Nat Genet. 2014 Feb;46(2):176-181. doi: 10.1038/ng.2856. Epub 2013 Dec 22.
10
Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding.健康献血者中的单克隆 B 细胞淋巴增生症:一种出乎意料的常见发现。
Blood. 2014 Feb 27;123(9):1319-26. doi: 10.1182/blood-2013-08-523704. Epub 2013 Dec 17.